Grifols SA risk profile

45 Elevated one input has moved against it

Measured 21 October 2026 from GRFS's filed statements. Recomputed nightly.

45 (Elevated), driven by Leverage and coverage at 59, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation41ElevatedStableOne-year price volatility — 32.1%
Operating pressure34NormalWorseningCosts outgrowing revenue — -0.8 percentage points
Cash conversion24NormalStableCapital spending against operating cash — 0.40x
Leverage and coverage59ElevatedEasingNet debt to EBITDA — 5.34x
Competitive position53ElevatedStableRevenue-growth gap against peers — -11.9 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Grifols SA